References Davies, M., Frch, L., Jeppesen, O.K., Pakseresht, A., Pedersen, S.D., Perreault, L., Rosenstock, J
Uwaga: Krtka ekspozycja na UV drastycznie przyspiesza procesy u badanych obiektw
Oral GLP-1 Formulations and Novel Delivery Systems: With the successful formulation and commercialization of oral semaglutide (Rybelsus), there is now a way to remove barriers to injecting doses of the GLP-1 therapy and thus achieve a more widespread adoption among patients
This would not only enhance its access to China's growing weight-loss market but also shore up global supply